OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
Clare Burn Aschner, Krithika Muthuraman, Iga Kucharska, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 697
Open Access | Times Cited: 8
Clare Burn Aschner, Krithika Muthuraman, Iga Kucharska, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 697
Open Access | Times Cited: 8
Showing 8 citing articles:
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development
Julie Ostrowsky, Leah C. Katzelnick, Nigel Bourne, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 3
Julie Ostrowsky, Leah C. Katzelnick, Nigel Bourne, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 3
Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions
Randy Yoo, Matthijs M. Jore, Jean‐Philippe Julien
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Randy Yoo, Matthijs M. Jore, Jean‐Philippe Julien
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Next generation of multispecific antibody engineering
Dániel Kéri, Matt Walker, Isha Singh, et al.
Antibody Therapeutics (2023) Vol. 7, Iss. 1, pp. 37-52
Open Access | Times Cited: 21
Dániel Kéri, Matt Walker, Isha Singh, et al.
Antibody Therapeutics (2023) Vol. 7, Iss. 1, pp. 37-52
Open Access | Times Cited: 21
Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort
Amy Nouanesengsy, Anthony Semesi, Kim Ưng Quách, et al.
Microbiology Spectrum (2025)
Open Access
Amy Nouanesengsy, Anthony Semesi, Kim Ưng Quách, et al.
Microbiology Spectrum (2025)
Open Access
Single-Molecule Mapping Landscape of Multivalent Antibody-DNA Framework Conjugates
Qinglin Xia, Mo Zhou, Xia Liu, et al.
ACS Applied Bio Materials (2025)
Closed Access
Qinglin Xia, Mo Zhou, Xia Liu, et al.
ACS Applied Bio Materials (2025)
Closed Access
Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Forty years of HIV research inspires the development of SARS-CoV-2 therapy
Roberto Patarca, William A. Haseltine
Journal of Molecular Cell Biology (2023) Vol. 15, Iss. 10
Open Access | Times Cited: 1
Roberto Patarca, William A. Haseltine
Journal of Molecular Cell Biology (2023) Vol. 15, Iss. 10
Open Access | Times Cited: 1
Biparatopic anti-PCSK9 antibody enhances the LDL-uptake in HepG2 cells
Xinyang Li, Wei Zhang, Shu Yu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Xinyang Li, Wei Zhang, Shu Yu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
